AI-Powered Ligand-Based Design Targeting YCK1 and YCK2 in Saccharomyces cerevisiae: Implications for Modulating Kinase Signaling Pathways in Drug Discovery
AI-driven ligand-based design identified stable inhibitors for YCK1 and YCK2 with strong binding affinities and favorable pharmacokinetic profiles. These ligands could serve as leads for developing therapeutic agents targeting kinase…
S. Harrizi, Y. Zaidoune, R. Amal and 5 others
Presented at 2nd International e-Health Forum (IeHF 2024), Casablanca, 30–31 October 2024
